Literature DB >> 10380893

Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides.

S Heidenreich1.   

Abstract

Like all other immune system cells, monocytes and macrophages may undergo apoptotic cell death in response to specific triggers and mediators or as a consequence of aging. However, factors inducing apoptosis and the involved cellular and molecular mechanisms are much better investigated and understood for lymphocytes. Th2 cell-derived cytokines such as interleukin-4 (IL-4) are able to induce monocyte apoptosis most effectively. This process is preceded by down-regulation of the CD14 surface receptor. Mediators such as lipopolysaccharide (LPS) suppress and postpone apoptosis in parallel with up-regulation of CD14. Macrophages are rather resistant against apoptotic damage, and factors able to evoke apoptosis in monocytes are often ineffective in macrophages. Resistance of macrophages against apoptotic triggers may be beneficial for inflammatory processes where macrophages are engaged and needed as phagocytes for ingestion and removal of moribund cells. The multifunctional CD14 receptor of monocytes/macrophages is supposed to be involved in the apoptotic network on both sides: as a surface molecule of monocytes that can promote survival and antagonize apoptosis and as a recognition receptor of macrophages that enables or supports interaction with apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380893     DOI: 10.1002/jlb.65.6.737

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  16 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Authors:  Claudia Macaubas; Khoa Nguyen; Chetan Deshpande; Carolyn Phillips; Ariana Peck; Tzielan Lee; Jane L Park; Christy Sandborg; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-10-29       Impact factor: 3.969

3.  Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells.

Authors:  S M Foskett; R Ghose; D N Tang; D E Lewis; A P Rice
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  The regulation of FasL expression--a distinquishing feature between monocytes and T lymphocytes/NK cells with possible implications for SLE.

Authors:  K Eneslätt; S Rantapää-Dahlqvist; A Uddhammar; K G Sundqvist
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

5.  Cyclin-dependent kinase 9 may as a novel target in downregulating the atherosclerosis inflammation (Review).

Authors:  Yeming Han; Yang Zhan; Guihua Hou; Li Li
Journal:  Biomed Rep       Date:  2014-07-31

6.  Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver.

Authors:  Salamah Mohammad Alwahsh; Min Xu; Hatice Ali Seyhan; Shakil Ahmad; Sabine Mihm; Giuliano Ramadori; Frank Christian Schultze
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 7.  CD14 and toll-like receptor 4: a link between infection and acute coronary events?

Authors:  R Arroyo-Espliguero; P Avanzas; S Jeffery; J C Kaski
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 8.  Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis.

Authors:  Zhang Chi; Alirio J Melendez
Journal:  Cell Adh Migr       Date:  2007-10-20       Impact factor: 3.405

9.  Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.

Authors:  Li-Ying Liou; Christine H Herrmann; Andrew P Rice
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  The patterns of in vitro cell-death and inflammatory cytokines induced by distinct BCG vaccine strains are differentially induced in human mononuclear cells.

Authors:  C Ponte; M Hacker; M Moraes; L Castello-Branco; F Silva; P Antas
Journal:  Hum Vaccin Immunother       Date:  2017-11-27       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.